Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis – Nature.com

Commisso, C. et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497, 633–637 (2013).

Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75, 544–553 (2015).

Fennell, M., Commisso, C., Ramirez, C., Garippa, R. & Bar-Sagi, D. High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis. Assay Drug Dev. Technol. 13, 347–355 (2015).

Stransky, L., Cotter, K. & Forgac, M. The function of v-ATPases in cancer. Physiol. Rev. 96, 1071–1091 (2016).

Furuchi, T., Aikawa, K., Arai, H. & Inoue, K. Bafilomycin A₁, a specific inhibitor of vacuolar-type H⁺-ATPase, blocks lysosomal cholesterol trafficking in macrophages. J. Biol. Chem. 268, 27345–27348 (1993).

Iliev, A. I., Djannatian, J. R., Nau, R., Mitchell, T. J. & Wouters, F. S. Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin. Proc. Natl Acad. Sci. USA 104, 2897–2902 (2007).

del Pozo, M. A. et al. Integrins regulate Rac targeting by internalization of membrane domains. Science 303, 839–842 (2004).

Kozik, P. et al. A human genome-wide screen for regulators of clathrin-coated vesicle formation reveals an unexpected role for the V-ATPase. Nat. Cell Biol. 15, 50–60 (2013).

Plowman, S. J., Muncke, C., Parton, R. G. & Hancock, J. F. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc. Natl Acad. Sci. USA 102, 15500–15505 (2005).

Li, T. & Chiang, J. Y. L. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res. 2009, 501739 (2009).

Garbarino, J. et al. STARD4 knockdown in HepG2 cells disrupts cholesterol trafficking associated with the plasma membrane, ER, and ERC. J. Lipid Res. 53, 2716–2725 (2012).

Capecci, J. & Forgac, M. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells. J. Biol. Chem. 288, 32731–32741 (2013).

Nishisho, T. et al. The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cells. Mol. Cancer Res. 9, 845–855 (2011).

Chung, C. et al. The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab. Invest. 91, 732–743 (2011).

Deffieu, M. S. & Pfeffer, S. R. Niemann–Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc. Natl Acad. Sci. USA 108, 18932–18936 (2011).

Breton, S., Lisanti, M. P., Tyszkowski, R., McLaughlin, M. & Brown, D. Basolateral distribution of caveolin-1 in the kidney. Absence from H⁺-ATPase-coated endocytic vesicles in intercalated cells. J. Histochem. Cytochem. 46, 205–214 (1998).

Breton, S. & Brown, D. Regulation of luminal acidification by the V-ATPase. Physiology (Bethesda) 28, 318–329 (2013).

Chen, Y. et al. Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science 289, 625–628 (2000).

Gorbatenko, A., Olesen, C. W., Boedtkjer, E. & Pedersen, S. F. Regulation and roles of bicarbonate transporters in cancer. Front. Physiol. 5, 130 (2014).

Romero, M. F., Chen, A.-P., Parker, M. D. & Boron, W. F. The SLC4 family of bicarbonate (HCO₃
⁻) transporters. Mol. Aspects Med. 34, 159–182 (2013).

Gorbatenko, A. et al. ErbB2 upregulates the Na⁺,HCO₃
⁻-cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4. FASEB J. 28, 350–363 (2014).

Haigler, H. T., McKanna, J. A. & Cohen, S. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J. Cell Biol. 83, 82–90 (1979).

Amyere, M. et al. Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol. Biol. Cell 11, 3453–3467 (2000).

Koivusalo, M. et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 188, 547–563 (2010).

Nimnual, A. S., Taylor, L. J., Nyako, M., Jeng, H. H. & Bar-Sagi, D. Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b. Small GTPases 1, 89–97 (2010).

Yeung, T. et al. Receptor activation alters inner surface potential during phagocytosis. Science 313, 347–351 (2006).

Orellana, S. A. & McKnight, G. S. Mutations in the catalytic subunit of cAMP-dependent protein kinase result in unregulated biological activity. Proc. Natl Acad. Sci. USA 89, 4726–4730 (1992).

Franceschini, A. et al. STRING v9.1: protein–protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808–D815 (2013).

Commisso, C., Flinn, R. J. & Bar-Sagi, D. Determining the macropinocytic index of cells through a quantitative image-based assay. Nat. Protoc. 9, 182–192 (2014).

Bolte, S. & Cordelières, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213–232 (2006).

Pike, J. A., Styles, I. B., Rappoport, J. Z. & Heath, J. K. Quantifying receptor trafficking and colocalization with confocal microscopy. Methods 115, 42–54 (2017).

Kamiyama, D. et al. Versatile protein tagging in cells with split fluorescent protein. Nat. Commun. 7, 11046 (2016).

Sato, I. et al. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J. Cell Sci. 122, 965–975 (2009).

Walsh, A. B. & Bar-Sagi, D. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J. Biol. Chem. 276, 15609–15615 (2001).

Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G. & Bar-Sagi, D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836–847 (2012).

Badea, L., Herlea, V., Dima, S. O., Dumitrascu, T. & Popescu, I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55, 2016–2027 (2008).

Pei, H. et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259–266 (2009).